KFDA mulls use of Bacchus-S as tradename of quasi-drug

Published: 2004-10-19 07:00:00

Updated: 2004-10-19 07:00:00

A review on the permissible use of Bacchus-S as another tradename of quasi-drug, which is similar to Bacchus-F drink as a prescription drug, has been underway, according to the Korea Food and Drug Administration.

Dong-A has filed its application to the regional KFDA in the tradename of Bacchus...

Fees

- Email service daily and homepage access.

$300 per month. ($3,240 per year)
5 Email holders per each company.
Anual contract base.

Latest News

Which are outstanding tetravalent vaccines even for the young?

Disease treated the most with clinical trial drugs is respiratory disorder like lung cancer

Who will be the next Pharmaceutical Safety Bureau Director?

Celltrion completes clinical trials for Remsima SC for European approval

Sales listed pharmas made in the first half of the year

TOP

BACK